PanCancerT

A biotechnology company spun out of Erasmus MC developing TCR-T cell therapies for cancer

Biotech & Life Sciences

Sector

Biotechnology therapeutics development

Model

01Company Overview

A biotechnology company spun out of Erasmus MC developing TCR-T cell therapies for cancer. Its lead clinical candidate, PCT1:CO-STIM, is being developed for triple-negative breast cancer.

02Backed By1 investor

TCThuja Capital Management→

03Similar Companies

Is this your company? Claim your profile

TT

TCR2 Therapeutics

Biotech & Life Sciences

→

NT

Neogene Therapeutics

Biotech & Life Sciences

→

A

Adaptimmune

Biotech & Life Sciences

→

T

T-Knife

Biotech & Life Sciences

→

MT

Marker Therapeutics

Biotech & Life Sciences

→

04Startup DNA

9

signals

Sectors
Business Model
Technology